Everyday people are using AI tools like Claude and ChatGPT to create personalized 'micro apps' for dining recommendations, health tracking, and habit monitoring within days, potentially disrupting the subscription software model as individuals build custom solutions instead of paying monthly fees for existing products.
ARK Invest's Genomic Revolution Fund targets 30-50 DNA sequencing and gene editing companies including CRISPR technology firms, seeking long-term capital growth from healthcare, agriculture, and pharmaceutical innovations since 2014.
Chinese app 'Are You Dead Yet' rockets to number one on China's App Store by alerting emergency contacts when users fail to check in daily, attracting massive investment interest and solo dwellers seeking safety nets.
Scientists unveil groundbreaking quantum theory proposing consciousness emerges when brain glutamate neurotransmitters interact with quantum field fluctuations in space, with cortical microcolumns creating protected coherence domains that resist warm brain decoherence, potentially explaining how anesthesia disrupts these quantum interactions to cause unconsciousness.
Revolutionary AI-powered exoskeletons weighing under 4.4 pounds break the $1,000 barrier, targeting hikers and seniors as companies push for mainstream adoption like smartwatches, with one manufacturer already selling 20,000 units of the terrain-adapting devices.
A groundbreaking 'Surgical Humanoid' robot with two coordinated arms and dynamic vision now performs routine spinal surgeries at a Las Vegas hospital, while developers plan to integrate NVIDIA's AI technology for even greater surgical autonomy.
Protege Health secures $30 million from Andreessen Horowitz to expand its AI data marketplace that connects organizations with proprietary datasets to AI developers seeking training data, including medical records and imaging while ensuring privacy compliance.
CES 2026 unveils bizarre AI-powered products including smart hair clippers with real-time coaching feedback, mysterious 'AI-upgraded' vitamin pills being distributed at booths, and countless gadgets embedding artificial intelligence despite manufacturers struggling to explain what makes them truly AI-powered.
FDA eliminates regulatory oversight for AI health devices and wearables in sweeping deregulation move, allowing clinical decision support software to enter markets without review as Commissioner Makary prioritizes 'Silicon Valley speed' over traditional safety protocols.
Utah becomes the first state to legally allow AI to autonomously renew prescriptions for chronic conditions through a partnership with platform Doctronic, while federal legislation proposes expanding AI prescribing authority nationwide.